Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$10.71 - $18.33 $216,299 - $370,192
-20,196 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$11.78 - $16.98 $86,476 - $124,650
-7,341 Reduced 26.66%
20,196 $325,000
Q4 2021

Feb 10, 2022

BUY
$12.22 - $19.57 $336,502 - $538,899
27,537 New
27,537 $386,000
Q3 2021

Oct 28, 2021

SELL
$15.42 - $21.72 $195,309 - $275,105
-12,666 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$20.85 - $29.88 $96,723 - $138,613
-4,639 Reduced 26.81%
12,666 $264,000
Q1 2021

Jul 21, 2021

SELL
$24.75 - $39.14 $210,919 - $333,551
-8,522 Reduced 33.0%
17,305 $489,000
Q4 2020

Feb 12, 2021

SELL
$29.0 - $41.62 $1.08 Million - $1.54 Million
-37,074 Reduced 58.94%
25,827 $844,000
Q3 2020

Oct 30, 2020

BUY
$16.3 - $30.64 $32,632 - $61,341
2,002 Added 3.29%
62,901 $1.93 Million
Q2 2020

Aug 05, 2020

BUY
$7.95 - $18.81 $109,264 - $258,524
13,744 Added 29.15%
60,899 $993,000
Q1 2020

May 11, 2020

SELL
$6.45 - $14.04 $48,820 - $106,268
-7,569 Reduced 13.83%
47,155 $469,000
Q4 2019

Feb 13, 2020

BUY
$12.97 - $15.94 $709,770 - $872,300
54,724 New
54,724 $752,000
Q2 2019

Jul 08, 2019

SELL
$14.71 - $19.79 $199,747 - $268,728
-13,579 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$13.73 - $16.87 $3,734 - $4,588
-272 Reduced 1.96%
13,579 $225,000
Q4 2018

Feb 05, 2019

SELL
$10.6 - $17.49 $50,254 - $82,920
-4,741 Reduced 25.5%
13,851 $194,000
Q3 2018

Nov 02, 2018

BUY
$16.65 - $21.85 $309,556 - $406,235
18,592 New
18,592 $0

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $598M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.